United States News Todas as matérias

AbbVie (NYSE:ABBV) secured exclusive global rights to a novel cancer-fighting antibody from RemeGen Co. on Monday, marking one of the year’s largest oncology licensing agreements as the pharmaceutical giant moves to integrate next-generation bispecifics with its expanding "ADC" platform.

Shake Shack (NYSE:SHAK) signaled a period of aggressive expansion and improving profitability, issuing an upbeat 2026 outlook that highlights its evolution from a cult favorite to a dominant global restaurant platform.

GTCR announced the completion of its $24.25 billion sale of Worldpay to Global Payments (NYSE:GPN) on Monday, marking the conclusion of a complex three-way transaction that reshapes the landscape of the global payments industry.

SOPHiA GENETICS (NASDAQ:SOPH) reported a record-breaking performance for 2025, driven by a surge in demand for its AI-powered genomic analysis, as the company prepares for a major leadership transition and moves closer to profitability.

Viking Therapeutics (NASDAQ:VKTX) shares were in focus Monday after the company announced the peer-reviewed publication of its Phase 2 VENTURE study results, reinforcing the weight-loss potential of its lead candidate as it enters a pivotal year of Phase 3 testing.

OneSpaWorld Holdings Limited (NASDAQ:OSW) projected its annual revenue will surpass the $1 billion mark for the first time in 2026, as the company streamlines its global operations to capitalize on a record-breaking surge in cruise ship travel.

J.Jill (NYSE:JILL) raised its fourth-quarter and full-year financial guidance on Monday, citing a "stronger-than-anticipated" conclusion to the 2025 holiday season as the retailer prepares for key investor meetings at the ICR Conference.

Zura Bio Limited 9NASDAQ:ZURA) announced it is expanding the patient population for its mid-stage trial of tibulizumab in hidradenitis suppurativa (HS), a move intended to bolster the study’s statistical power as the company prepares for a critical data readout later this year.

Aura Minerals (NASDAQ:AUGO) reported record-breaking preliminary production for the fourth quarter of 2025, bolstered by the successful ramp-up of its Borborema mine and the initial integration of its newest acquisition in Brazil.

Lululemon Athletica (NASDAQ:LULU) raised its fourth-quarter profit and revenue forecasts, signaling that resilient holiday demand for its yoga-inspired apparel is helping the company navigate a cooling U.S. retail environment.

Summit Therapeutics (NASDAQ:SMMT) announced a clinical trial collaboration with GSK (NYSE:GSK) to evaluate the combination of ivonescimab, Summit’s novel investigational PD-1/VEGF bispecific antibody, with risvutatug rezetecan (GSK’227), GSK’s investigational B7-H3-targeting antibody-drug conjugate (ADC), in multiple solid tumor settings, including small cell lung cancer (SCLC).

Bellevue, Washington-based Savers Value Village (NYSE:SVV), a leading operator of for-profit thrift stores focused on second-hand apparel, home goods, and accessories, announced preliminary, unaudited net sales results for the fourteen-week fourth quarter and fifty-three-week fiscal year ended January 3, 2026, in connection with its participation in the ICR Conference January 12-14, 2026.

West Pharmaceutical Services (NYSE:WST), a leading provider of injectable packaging and delivery systems, announced it has entered into a definitive agreement to sell all manufacturing and supply rights for its SmartDose 3.5mL On-Body Delivery System, along with associated facilities, to AbbVie (NYSE:ABBV) for $112.5 million in cash at closing, subject to customary working capital and other adjustments.

Las Vegas-based Allegiant Travel Co. (NASDAQ:ALFT) and Minneapolis-based Sun Country Airlines Holdings (NASDAQ:SNCY) announced Sunday that Allegiant has agreed to acquire Sun Country in an all-cash-and-stock transaction valued at approximately $1.5 billion, marking the latest move in a wave of consolidation among smaller U.S. carriers.

Kyivstar (NASDAQ:KYIV), Ukraine's leading mobile operator and a subsidiary of VEON (NASDAQ:VEON), launched a 5G pilot network in the western city of Lviv on January 12, 2026, in collaboration with the Ministry of Digital Transformation of Ukraine.

Cytek Biosciences (NASDAQ:CTKB), a leading provider of cell analysis solutions including its flagship Aurora and Northern Lights spectral flow cytometry platforms, announced preliminary, unaudited revenue expectations for the fourth quarter and full year ended December 31, 2025.

Zymeworks (NASDAQ:ZYME), a clinical-stage biotechnology company developing novel, bispecific antibody therapeutics, provided a strategic update outlining key priorities for 2026, anchored by recent clinical and regulatory progress for its lead candidate Ziihera (zanidatamab-hrii).

Natera (NASDAQ:NTRA), a global leader in cell-free DNA testing and precision medicine, released preliminary unaudited financial and operational results for the fourth quarter and full year ended December 31, 2025.

Amsterdam, Netherlands- and Boston-based argenx SE (NASDAQ:ARGX), a global immunology company, reported preliminary full-year 2025 global product net sales of $4.15 billion, reflecting strong commercial momentum for its flagship FcRn antagonist VYVGART (efgartigimod) and its subcutaneous formulation VYVGART Hytrulo.

Elbit Systems (NASDAQ:ESLT) announced on Monday that it has been awarded contracts valued at approximately $275 million to supply an unnamed Asia-Pacific nation with advanced electronic warfare (EW) and missile defense suites for its helicopter platforms.

Fed chair Jerome Powell claims a DOJ investigation is linked to interest rate tensions with the Trump administration.

Monero has reached a record high, with traders drawing comparisons to silver’s explosive breakout pattern.

Stablecoin adoption in Venezuela and Iran highlights how Tether can both protect citizens and aid sanctions evasion.

Soaring energy prices are leaving millions of US families struggling to pay electricity and gas bills this winter.